IGO Limited (IIDDY)
| Market Cap | 2.72B +11.1% |
| Revenue (ttm) | 320.24M -12.3% |
| Net Income | 100.52M |
| EPS | 0.26 |
| Shares Out | n/a |
| PE Ratio | 26.91 |
| Forward PE | 10.80 |
| Dividend | 0.06 (0.78%) |
| Ex-Dividend Date | Sep 10, 2026 |
| Volume | 676 |
| Open | 7.10 |
| Previous Close | 7.61 |
| Day's Range | 7.10 - 7.10 |
| 52-Week Range | 6.75 - 11.98 |
| Beta | 0.74 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |
About IGO Limited
IGO Limited, together with its subsidiaries, discovers, develops, and delivers battery minerals in Australia. It operates through Nova Operation, Forrestania Operation, Cosmos Project, Lithium Business, and Growth segments. The company explores for nickel, lithium, copper, cobalt, and silver deposits. It is also involved in exploration, business development, and project evaluation activities, as well as sale of concentrates. In addition, the company offers shipping and insurance services. The company was formerly known as Independence Group NL ... [Read more]
News
IGO's Q1 Underlying EBITDA Rises
(RTTNews) - Australian miner IGO Ltd. (IGO.AX) Thursday reported higher underlying EBITDA in the first quarter compared with the previous quarter, supported by increased nickel sales volumes.
IGO Limited Earnings Call Transcript: Q1 2027
Record Greenbushes output and early CGP3 nameplate supported strong results, while Nova ended mining on track to exceed upgraded guidance. Future shareholder returns increasingly depend on TLEA distributions; port, Kwinana and safety challenges remain priorities.
IGO Limited Earnings release: Q1 2027
IGO Limited released its Q1 2027 earnings on October 28, 2026, summarizing the period's financial results.
IGO Limited Slides: Q1 2027
IGO Limited has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on October 28, 2026.
IGO Limited upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs upgraded IGO Limited (IPGDF) to Buy from Neutral with a A$9.50 price target The company’s Greenbushes chemical grade spodumene product and asset optimizations could add up to A$1B…
IGO Limited Earnings Call Transcript: H2 2026
Strong safety and operational performance drove significant earnings and cash flow improvements, with Nova and Greenbushes delivering standout results. The business ended FY26 with a robust balance sheet, resumed dividends, and clear priorities for FY27 focused on portfolio optimization and disciplined growth.
IGO Limited Earnings release: H2 2026
IGO Limited released its H2 2026 earnings on August 26, 2026, summarizing the period's financial results.
IGO Limited Slides: H2 2026
IGO Limited has posted slides in relation to its H2 2026 quarterly earnings report, which was published on August 26, 2026.
IGO Limited Annual report: H2 2026
IGO Limited has published its H2 2026 annual report on August 26, 2026.
IGO Limited Earnings Call Transcript: Q4 2026
FY 2026 closed with strong safety, operational, and financial results, highlighted by Nova exceeding production guidance and Greenbushes achieving top-end output and margins. Net cash rose to AUD 387 million, and the business remains focused on disciplined growth and portfolio optimization.
IGO Limited Slides: Q4 2026
IGO Limited has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on July 27, 2026.
IGO Limited Earnings release: Q4 2026
IGO Limited released its Q4 2026 earnings on July 27, 2026, summarizing the period's financial results.
IGO Limited Earnings Call Transcript: Q3 2026
Record safety and productivity at Nova drove strong financials, while Greenbushes faced operational and safety challenges, leading to revised guidance and reduced CapEx. Group EBITDA reached AUD 119 million, with a net cash position of AUD 327 million.
IGO Limited Earnings release: Q3 2026
IGO Limited released its Q3 2026 earnings on April 23, 2026, summarizing the period's financial results.
IGO Limited Slides: Q3 2026
IGO Limited has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on April 23, 2026.
IGO Limited Earnings Call Transcript: H1 2026
Half-year results showed improved cost discipline and operational performance at Nova, while Greenbushes faced operational challenges but maintained strong margins. Revenue and EBITDA declined year-over-year, but cash flow and balance sheet remain robust, with a focus on disciplined capital allocation and growth at Greenbushes.
IGO Limited Quarterly report: H1 2026
IGO Limited has published its H1 2026 quarterly earnings report on February 18, 2026.
IGO Limited Slides: H1 2026
IGO Limited has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 18, 2026.
IGO Limited price target raised to A$5.80 from A$5.40 at Jefferies
Jefferies raised the firm’s price target on IGO Limited (IPGDF) to A$5.80 from A$5.40 and keeps an Underperform rating on the shares after making a mid-quarter update to the firm’s…
IGO Limited Earnings Call Transcript: Q2 2026
Strong operational and financial results were delivered, with Nova and Greenbushes driving positive cash flow and high margins. CGP3 ramp-up at Greenbushes is progressing, supporting further growth amid a buoyant lithium market.
IGO Limited Earnings release: Q2 2026
IGO Limited released its Q2 2026 earnings on January 28, 2026, summarizing the period's financial results.
IGO Limited Slides: Q2 2026
IGO Limited has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on January 28, 2026.
IGO Limited upgraded to Buy from Hold at Canaccord
Canaccord upgraded IGO Limited (IPGDF) to Buy from Hold with a price target of A$10.10, up from A$7.30. Updates to the firm’s 2026 and 2027 price deck result in an…
IGO Limited downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded IGO Limited (IPGDF) to Sector Perform from Outperform with a price target of A$6.50, up from A$5.50. The firm adjusted ratings in Australian mining as part of…
IGO Limited Transcript: AGM 2025
The AGM addressed a challenging year marked by significant impairments, a net loss, and strategic resets, but highlighted strong performance at Greenbushes and a renewed focus on battery materials. Board renewal, leadership changes, and a clear growth strategy to 2035 were emphasized.